Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-196P (RNA, U6 small nuclear 196, pseudogene) is a genomic sequence in humans annotated as a pseudogene variant of U6 small nuclear RNA. U6 snRNA itself is an essential spliceosomal RNA that participates in pre-mRNA splicing, but RNU6-196P is a sequence copy thought to be non-functional and not expressed as a protein or functional RNA. Pseudogenes like RNU6-196P are generally not used in research or clinical contexts as drug targets, biomarkers, or functional enzymes/receptors. This gene is a nonfunctional pseudogene and does not serve as a drug target, receptor, or biomarker. There is no evidence of biological function, disease association, interacting drugs, action mechanisms, or safety concerns. It should be marked as incorrect for therapeutic listing purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 196, pseudogene (RNU6-196P).